Wiener J D
Clin Nucl Med. 1985 Apr;10(4):256-9.
A follow-up study is presented in 88 patients treated with I-131 for Plummer's disease (localized autonomous thyroid function, either multifocal or as a solitary nodule) one to 17 years before the present study. Studies included clinical examination, scintigraphy, and function tests. One patient was hypothyroid, seven were marginally hyperthyroid, and five still received low dose antithyroid drugs. Of 75 euthyroid patients, the thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) was absent in 16 (generally with scintigraphic evidence of autonomous function), subnormal in 20, and normal in 39. A single autonomous nodule prior to treatment was found relatively frequently in males and in patients with a normal TRH test at follow-up. Most goiters had become smaller and one third of all solitary nodules could not be detected anymore. Autonomous function at follow-up was probably due to residual rather than recurrent disease in most, if not all, cases. It is concluded that I-131 therapy is at least as satisfactory as partial thyroidectomy in the treatment of Plummer's disease; lifelong follow-up was not found to be necessary.
本文介绍了一项针对88例接受I - 131治疗的普卢默病(局限性自主性甲状腺功能,可为多灶性或单个结节)患者的随访研究,这些患者在本研究开展前1至17年接受了治疗。研究内容包括临床检查、闪烁扫描和功能测试。1例患者为甲状腺功能减退,7例为轻度甲状腺功能亢进,5例仍在服用低剂量抗甲状腺药物。在75例甲状腺功能正常的患者中,16例对促甲状腺激素释放激素(TRH)无促甲状腺激素(TSH)反应(通常闪烁扫描有自主性功能证据),20例反应低于正常,39例反应正常。治疗前单个自主性结节在男性以及随访时TRH试验正常的患者中相对常见。大多数甲状腺肿变小,所有单个结节中有三分之一已无法检测到。随访时的自主性功能在大多数(如果不是全部)病例中可能是由于残留疾病而非复发疾病所致。结论是,I - 131治疗在普卢默病的治疗中至少与部分甲状腺切除术一样令人满意;未发现有必要进行终身随访。